In this episode, Subhi Saadeh sits down with Elaine (Yi Ling Tan), Creator and Principal Consultant at MedTech Chopsticks, to break down China medical device market access and regulatory compliance under the NMPA.

The conversation explores why Western companies often underestimate China’s regulatory expectations — particularly when assuming EU or U.S. approvals, ISO standards, or FDA clearances will translate directly. Elaine explains how China requires demonstration of safety and effectiveness against applicable local standards primarily GB (national standards) and YY (medical device industry standards) including both mandatory and recommended variants (e.g., GB vs GB/T, YY vs YY/T).

The episode dives into China’s local type testing model and the role of Product Technical Requirements (PTRs) in defining test methods, parameters, accessories, and applicable standards for registration.

Elaine also outlines how China’s quality system expectations align to China Medical Device GMP rather than ISO 13485 including major GMP updates taking effect in November 2026 and discusses implications for foreign manufacturers.

Additional discussion topics include China agents and authorized representatives, clinical evaluation expectations, post-market reporting requirements, and how China’s device classification system can influence regulatory strategy.

⏱️ Timestamps

00:00 Welcome + Meet Elaine (MedTech Chopsticks)

00:38 Why China Is Different: Local Standards vs EU/US Assumptions

03:35 GB & YY Standards Explained (National vs Industry Standards)

05:07 Local Type Testing & PTRs: Building China Product Technical Requirements

06:52 China GMP Updates: Key Differences vs ISO 13485

12:42 China Agent vs EU Authorized Rep: Roles & Responsibilities

15:19 Choosing Local Test Labs: NMPA-Designated Testing Considerations

18:42 Planning Early: Standards Gaps, Clinical Evaluation & PMS Risks

24:43 China Certification & Device Classification Changes (Class I/II/III)

28:38 Where to Find Elaine + Closing

Subhi Saadeh is the Founder and Principal at Let's Combinate. With a background in Quality, Manufacturing Operations and R&D he's worked in Large Medical Device/Pharma organizations to support the development and launch of Hardware Devices, Disposable Devices, and Combination Products for Vaccines, Generics, and Biologics. Subhi serves currently as the International Committee Chair for the Combination Products Coalition(CPC) and as a member of ASTM Committee E55 and also served as a committee member on AAMI's Combination Products Committee.For questions, inquiries or suggestions please reach out at letscombinate.com or on the show's LinkedIn Page.